Coriolis Pharma News Today

Coriolis Pharma secures investment from KKR to support next steps in growth and to expand global footprintNewly formed KKR platform Frontier Biosolutions and its globally renowned experts will serve as advisors to Coriolis PharmaMARTINSRIED-MUNICH, Germany, October 16, 2023 / B3C newswire / -- Coriolis Pharma, a glo...

KKR and Flerie to support organic and inorganic growth to extend Coriolis’ leadership position in formulation development and analytical services for innovative high-value biologics and cell and...

KKR & Co Inc (NYSE: KKR), in collaboration with Flerie, disclosed the formation of a new 

KKR and Flerie to support organic and inorganic growth to extend Coriolis’ leadership position in formulation development and analytical services for innovative high-value biologics and cell and gene therapy productsExperienced team of biopharma services veterans led by Thomas Eldered of Flerie Invest AB (“Flerie”)...

  Coriolis Pharma extends its service portfolio by integrating RheaVita’s single vial unit (SVU) technology for continuous and controlled freeze-drying to stabilize novel modalities as part of biologics drug product development for clients. MARTINSRIED-MUNICH, Germany, July 31, 2023 / B3C newswire / -- Cor...

Prof. Dr. Reza Nejadnik's research at the University of Iowa, College of Pharmacy, is focused on protein pharmaceuticals, their formulation and characterization, and interaction of biologics with interfaces.MARTINSRIED-MUNICH, Germany, February 01, 2023 / B3C newswire / -- Coriolis Pharma, a globally operating servi...

Coriolis Pharma, a globally operating service provider and one of the world leaders in formulation research and development of (bio)pharmaceutical drugs, including cell and gene therapy products and vaccines, is strengthening its scientific advisory board with the appointment of Bruce Kerwin ...

Coriolis Pharma, a globally operating contract research and development organization (CRDO) and one of the world leaders in formulation research and development of (bio)pharmaceutical drugs, ATMP´s and vaccines, is expanding its current headquarters to form a new Campus as the next step in its growth strategy ...

Coriolis Pharma is substantially expanding its current headquarters with additional facilities to form a new Campus.MARTINSRIED-MUNICH, Germany, June 03, 2022 / B3C newswire / -- Coriolis Pharma, a globally operating contract research and development organization (CRDO) and one of the world leaders in formulation re...

Coriolis Pharma and U-Medico Announce a Strategic AllianceCoriolis Pharma (Martinsried, Germany) and U-Medico (Osaka, Japan) will join forces to provide science-driven and innovative formulation development services for clients worldwide.MARTINSRIED, Germany and OSAKA, Japan, March 17, 2022 / B3C newswire / -- Corio...